Search results for "FARMACEUTICO"

showing 10 items of 419 documents

A hyaluronic acid/cyclodextrin based injectable hydrogel for local doxorubicin delivery to solid tumors

2020

Localized delivery of anticancer drugs is often the most useful therapeutic approach for the treatment of solid tumors. The use of injectable polymeric systems that maximize drug concentration in the proximal area of the tumor represents an extremely advantageous therapeutic strategy. Here, the development of an injectable in situ forming hydrogel was accomplished by exploiting the azo-type Michael reaction between an amine derivative of hyaluronic and vinylsulfone functionalized -cyclodextrins complexing doxorubicin. This injectable system can be easily prepared and administered with timelines compatible with normal operating room procedures, as demonstrated by rheological tests. In vitro…

medicine.medical_treatmentPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineAnimal modelIn vivoNeoplasmsHyaluronic acidmedicineAnimalsDoxorubicinHyaluronic Acidchemistry.chemical_classificationCyclodextrinsChemotherapyCyclodextrinChemistryHydrogels021001 nanoscience & nanotechnologyIn vitroDrug concentrationDoxorubicinLocalized chemotherapy hyaluronic acid cyclodextrins in situ forming hydrogel DoxorubicinSettore CHIM/09 - Farmaceutico Tecnologico Applicativo0210 nano-technologyBiomedical engineeringmedicine.drug
researchProduct

Synthesis of Biocompatible and Biodegradable Polyamidoamines Microgels via a Simple and Reliable Statistical Approach.

2022

Polyamidoamines (PAAs) are biocompatible and biodegradable polymers with a huge potential as biomaterials for pharmaceutical applications. They are obtained by the step-wise aza-Michael polyaddition of bifunctional or multifunctional amines with bisacrylamides in water. To the best of our knowledge, no synthetic protocols leading to hyperbranched PAAs as well as PAA microgels have been published so far. To fill this gap, a statistical approach was established in this work to fine-tune the aza-Michael polyaddition stoichiometry when a multifunctional co-monomer (bf) is added to a mixture of bifunctional monomers with complementary functions (a2 + b2), possibly even in presence of a monofunct…

microgelspolyamidoamines; microgels; drug delivery; polyaddition; biodegradable polymersSettore CHIM/09 - Farmaceutico Tecnologico Applicativopolyamidoaminesbiodegradable polymers; drug delivery; microgels; polyaddition; polyamidoamines;biodegradable polymersdrug deliveryGeneral Materials SciencepolyadditionSettore CHIM/04 - Chimica IndustrialeMaterials (Basel, Switzerland)
researchProduct

PARTICELLE MICROMETRICHE, LORO METODO DI PREPARAZIONE E LORO USI

2019

La presente invenzione si riferisce a particelle micrometriche comprendenti il decanoato di cetile, al loro metodo di preparazione e a loro usi. In particolare, le particelle dell’invenzione sono utili per favorire l’assorbimento transpiteliale di principi attivi scarsamente solubili e/o permeabili.

microparticelleSettore CHIM/09 - Farmaceutico Tecnologico Applicativoparticelle micrometricheassorbimento transepiteliale
researchProduct

Hyaluronic acid based microparticles for applications in regenerative medicine

2018

microparticleSettore CHIM/09 - Farmaceutico Tecnologico Applicativotissue engineeringhyaluronic acid
researchProduct

Veicolazione tramite sistemi nanoparticellari lipidici solidi di molecole di interesse biologico

2012

nanoparticellariSettore CHIM/09 - Farmaceutico Tecnologico Applicativolipidici solidi
researchProduct

PREPARAZIONE E CARATTERIZZAZIONE DI NANOSISTEMI LIPIDICI PER IL DIREZIONAMENTO E IL RILASCIO MODIFICATO DI FARMACI E ACIDI NUCLEICI IN TERAPIA ONCOLO…

2016

sono stati sviluppati sistemi nanoparticellari in grado di intrappolare elevate quantità di farmaci e di legare materiale genico. I sistemi preparati sono stati caratterizzati da un punto di vista chimico-fisico e tecnologico farmaceutico. Sono stati infine utilizzati per prove in vitro e i risultati ottenuti hanno mostrato che essi possiedono le caratteristiche per potere essere considerati dei validi carrier per farmaci e materiale genico nel trattamento oncologico.

nanoparticelleterapia genicatumorecarcinoma ovariconanoparticelle; cancro; terapia genica; antitumorali; drug delivery; epatocarcinoma; carcinoma ovaricocaratterizzazioneSettore CHIM/09 - Farmaceutico Tecnologico Applicativodrug and gene deliverydrug deliverycancroantitumoraliepatocarcinoma
researchProduct

SUPERPARAMAGNETIC HYDROPHOBIC POLYASPARTAMIDE NANOPARTICLES FOR ANTICANCER DRUG DELIVERY

2012

nanoparticles PHEA drug delivery system anticancer drugSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases

2015

nanoparticles silibininSettore CHIM/09 - Farmaceutico Tecnologico Applicativoocular diseases
researchProduct

Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment

2017

Curcumin is a natural molecule with proved anticancer efficacy on several human cancer cell lines. However, its clinical application has been limited due to its poor bioavailability. Nanocarrier-based drug delivery approaches could make curcumin dispersible in aqueous media, thus overtaking the limits of its low solubility. The aim of this study was to increase the bioavailability and the antitumoral activity of curcumin, by entrapping it into nanostructured lipid carriers (NLCs). For this purpose here we describe the preparation and characterization of three kinds of curcumin-loaded NLCs. The nanosystems allowed the achievement of a controlled release of curcumin, the amounts of curcumin r…

nanostructured lipid carriers curcumin drug release cancer epithelial ovarian cellsCurcuminNanoparticleAdministration Oral02 engineering and technologyPharmacologynanostructured lipid carrier03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsNanoparticleSettore BIO/10 - BiochimicamedicineHumanscancerParticle SizeDrug Carrierdrug releaseCell ProliferationOvarian NeoplasmsDrug CarriersOvarian NeoplasmChemistry (all)General ChemistryLipid021001 nanoscience & nanotechnologyBiocompatible materialmedicine.diseaseControlled releaseLipidsBioavailabilitychemistryAgricultural and Biological Sciences (all)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisDrug deliveryCurcuminNanoparticlesFemaleNanocarriers0210 nano-technologyGeneral Agricultural and Biological SciencesOvarian cancerDrug Delivery Systemepithelial ovarian cellHuman
researchProduct

Silibilina per il trattamento delle patologie oculari neurodegenerative e formulazioni comprendenti nanostrutture per la sua veicolazione

2014

nanostrutture silibilina patologie oculariSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct